共 50 条
- [41] Four-Way Crossover Phase 1 Thorough QT Study to Assess Cardiac Safety of Domperidone and Consideration for Design and Conduct of QT/QTc Study in China [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (06): : 734 - 743
- [42] Near-thorough QT study as part of a first-in-man study [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 48 (10): : 1146 - 1157
- [43] Pharmacogenetic issues in thorough QT trials [J]. MOLECULAR DIAGNOSIS & THERAPY, 2006, 10 (03) : 153 - 162
- [45] Pharmacogenetic Issues in Thorough QT Trials [J]. Molecular Diagnosis & Therapy, 2006, 10 : 153 - 162
- [46] Robust Inference in Thorough QT Studies [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S59 - S59
- [47] Weaning off Thorough QT Studies [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (01) : 11 - 13
- [48] Practice and challenges of thorough QT studies [J]. JOURNAL OF ELECTROCARDIOLOGY, 2012, 45 (06) : 582 - 587
- [49] Toward Replacement of Thorough QT Studies [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (02) : 281 - 282
- [50] Evaluation of Eslicarbazepine Acetate on Cardiac Repolarization in a Thorough QT/QTc Study [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 52 (02): : 222 - 233